Cited by 767Hormonal and reproductive studiesHypothalamic control of reproductive hormonesAdrenal Hormones and Disorders

The DOI matches its Crossref record, with a small difference in title or year; 22 of the 24 references it cites were found in a registry or an index.

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

Open access

MULLIGAN, T., FRICK, M. F., ZURAW, Q. C., STEMHAGEN, A., MCWHIRTER, C.·2008·International Journal of Clinical Practice

DOI 10.1111/j.1742-1241.2006.00992.xPMC PMC1569444

Open this paper in CoChat — free account Open PDF

Abstract

The Hypogonadism in Males study estimated the prevalence of hypogonadism [total testosterone (TT) < 300 ng/dl] in men aged > or = 45 years visiting primary care practices in the United States. A blood sample was obtained between 8 am and noon and assayed for TT, free testosterone (FT) and bioavailable testosterone (BAT). Common symptoms of hypogonadism, comorbid conditions, demographics and reason for visit were recorded. Of 2162 patients, 836 were hypogonadal, with 80 receiving testosterone. Crude prevalence rate of hypogonadism was 38.7%. Similar trends were observed for FT and BAT. Among men not receiving testosterone, 756 (36.3%) were hypogonadal; odds ratios for having hypogonadism were significantly higher in men with hypertension (1.84), hyperlipidaemia (1.47), diabetes (2.09), obesity (2.38), prostate disease (1.29) and asthma or chronic obstructive pulmonary disease (1.40) than in men without these conditions. The prevalence of hypogonadism was 38.7% in men aged > or = 45 years presenting to primary care offices.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/j.1742-1241.2006.00992.x

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*
Gray, A., Feldman, H. A., McKinlay, J. B., & Longcope, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,104
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men
Morley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830
Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study
Araujo, A. B., O’Donnell, A. B., Brambilla, D. J., Simpson, W. B., Longcope, C., Matsumoto, A. M., & McKinlay, J. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031719 · Cited by 591
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men
Bèlanger, A., Candas, B., Dupont, A., Cusan, L., Diamond, P., Gomez, J.-L., & Labrie, F. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962278 · Cited by 437
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Evaluation and Treatment of Hypogonadism in Adult Male Patients—2002 Update
Petak, S. M., Nankin, H. R., Spark, R. F., Swerdloff, R. S., Rodriguez‐Rigau, L. J., Anderson, R. J., Bergman, D. A., Garber, J. R., Hamilton, C. R., Hershon, K. S., et al. (2002) · Endocrine Practice · doi:10.4158/ep.8.6.439 · Cited by 372
Plasma Free and Non-Sex-Hormone-Binding-Globulin Bound Testosterone Are Decreased in Obese Men in Proportion to Their Degree of Obesity
ZUMOFF, B., STRAIN, G. W., MILLER, L. K., ROSNER, W., SENIE, R., SERES, D. S., & ROSENFELD, R. S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-4-929 · Cited by 349
Blood Testosterone Threshold for Androgen Deficiency Symptoms
Kelleher, S., Conway, A. J., & Handelsman, D. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0143 · Cited by 273
Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study.
Gapstur, S. M., Gann, P. H., Kopp, P. A., Colangelo, L. A., Longcope, C., & Liu, K. (2002) · PubMed · Cited by 247

Show all 24 references

Research works printed but not linked: 2

Population Division US Census Bureau, 2005, Table 2: Annual estimates of the population by sex and selected age groups for the United States: April 1, 2000 to July 1, 2003 (NC-EST2003-02)
Centers for Disease Control, 2005, About minority health

Sorted by citations

Items 701–765 of 765

Männliche Luststörungen
Neuhof, C., & Hartmann, U. H. (2021) · Springer eBooks · doi:10.1007/978-3-662-62512-5_20
Fertility Preservation in Hypogonadal Men
Cohen, J. A., Rezk, A. H., & Ramasamy, R. (2022) · Springer eBooks · doi:10.1007/978-3-030-47767-7_39
Das Altern des Mannes
Saad, F. (2022) · Springer eBooks · doi:10.1007/978-3-662-61417-4_9
Hypogonadisme en een kinderwens, hebben we opties om te behandelen?
van Breda, J., & de Kemp, V. F. (2022) · Tijdschrift voor Urologie · doi:10.1007/s13629-022-00348-z
Current World Literature
(2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3281de7489
Sexual Function in Men and Women with Diabetes
Price, D. E. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch49
Factors Associated with Serum Testosterone Levels in Obese Men Aged 20–39 Years
Kim, Y.-B., Lee, J.-H., Kim, S.-J., Yu, B.-Y., & Kang, J. (2022) · Korean Journal of Family Practice · doi:10.21215/kjfp.2022.12.1.48
Testosterone and Male Infertility
Hsieh, T., McIntyre, M. G., & Lipshultz, L. I. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4405-2_7
Testosterontherapie: Welche Indikationen sind korrekt?
Gnad, A. (2022) · Journal für Urologie und Urogynäkologie/Österreich · doi:10.1007/s41972-021-00153-7
Urologic Endocrinology
Mirone, V. G., & Rocca, R. L. (2020) · Springer eBooks · doi:10.1007/978-3-030-28599-9_9
Male and Female Sexual Function and Dysfunction; Andrology
Seftel, A. D. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.08.079
Erectile Dysfunction and Cardiovascular Disease: A Review
(2013) · Journal of Andrology and Gynaecology · doi:10.13188/2332-3442.1000007
Clomiphene Citrate is a Safe and Effective Alternative to Testosterone Replacement in Male Hypogonadism with Type 2 Diabetes Mellitus
(2021) · doi:10.31038/edmj.2021512
Faculty Opinions recommendation of Indications for the use of human chorionic gonadotropic hormone for the management of infertility in hypogonadal men.
Minhas, S., Tharakan, T., & Miah, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735091493.793556544
Cambios en las hormonas sexuales en varones mayores de 50 años: Prevalencia de niveles bajos de testosterona y factores de riesgo
Jabaloyas, J. M. M., Zaragoza, A. Q., Cortés, C., Zaragozá, J. A. Q., Salom, M. G., & Nuez, P. C. (2008) · Actas Urológicas Españolas · doi:10.4321/s0210-48062008000600005
The Metabolic Investigation of Erectile Dysfunction: Cardiometabolic Risk Stratification
Miner, M. M. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000386
Testosterone Therapy in Men on Active Surveillance
Chun, T., Tannenbaum, J., Watts, H., Voznesensky, I., Almajed, W., & Hellstrom, W. J. G. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2022.0004
Seneszenz und Altershypogonadismus
Rolf, C., Zitzmann, M., & Nieschlag, E. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-61904-9_25-1
Variación geográfica en la prevalencia de asma en niños mexicanos durante la pandemia de la COVID-19
Bedolla-Pulido, T. R., Morales‐Romero, J., Bedolla-Pulido, A., Meza-López, C., Valdez-Soto, J. A., & Bedolla‐Barajas, M. (2023) · Revista Alergia México · doi:10.29262/ram.v69i4.1116
Biomarkers to Be Used for Decision of Treatment of Hypogonadal Men with or without Insulin Resistance
Zolla, L. (2023) · Metabolites · doi:10.3390/metabo13060681
Testosteronmangel - eine interdisziplinäre Herausforderung
Sommer, F. O., Szarvas, T., Baumhäkel, M., & Jäger, T. (2023) · Uro-News · doi:10.1007/s00092-023-5701-3
Seneszenz und Altershypogonadismus
Rolf, C., Zitzmann, M., & Nieschlag, E. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-61901-8_25
Testosterone undecanoate treatment for muscle weakness in a male with hypogonadotropic hypogonadism delayed puberty: A case report
Rizal, D. M., & Septiyorini, N. (2022) · Jurnal kedokteran dan kesehatan Indonesia · doi:10.20885/jkki.vol13.iss2.art14
LIFESTYLE-RELATED PREDICTORS OF TESTOSTERONE DEFICIENCY AMONG MALE PATIENTS WITH CHRONIC SPINAL CORD INJURY
Sharma, A., Prakash, O., Mahala, U., & Parihar, R. S. (2023) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2023.v16i7.47101
Male Hypogonadism and Aging: An Update
Iglesias, P., Núñez, A., & Díez, J. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_9
ĐẶC ĐIỂM LÂM SÀNG, CẬN LÂM SÀNG VÀ XÁC ĐỊNH MỘT SỐ YẾU TỐ LIÊN QUAN ĐẾN SUY SINH DỤC Ở NAM GIỚI ĐẾN ĐIỀU TRỊ TẠI BỆNH VIỆN TRƯỜNG ĐẠI HỌC Y DƯỢC CẦN THƠ
Nguyễn, Đ. N. N., Dụng, H. C. T., Nguyễn, T. L., Trần, P. D., Nguyễn, H. K., & Nguyễn, T. H. (2023) · Tạp chí Y Dược học Cần Thơ · doi:10.58490/ctump.2023i65.1864
Hypogonadism in the Male
Kavoussi, P. K., & Machen, G. L. (2023) · Cambridge University Press eBooks · doi:10.1017/9781009197533.033
Testosteronbehandlung: kein positiver Effekt auf den Progress eines Prädiabetes
Heinitz, S. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01195-9
Relação da Testosterona com a Obesidade e a Hipertensão Arterial
Póvoa, R. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20240138
Testosteron – der Einfluss eines Sexualhormons auf den männlichen Körper
Jäger, T. (2024) · Springer eBooks · doi:10.1007/978-3-662-68405-4_1
Male Reproductive Function
Hoffmann, I., & Behre, H. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00260-x
Prevalence of hypogonadism in men with and without chronic obstructive pulmonary disease: A cross-sectional study
Castro, H. M., Knoblovits, P., Furcada, J. M., Vito, E. L. D., Suarez, S. M., & Costanzo, P. (2024) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2024.05.010
Androgen receptor gene CAG-trinucleotide repeat length affects function of endothelium in men with hypogonadism and type 2 diabetes mellitus
Khripun, I., Ismailov, R. S., Белоусов, И. И., Ibishev, K. S., & Коган, М. И. (2024) · Urology Herald · doi:10.21886/2308-6424-2024-12-4-14-22
Male sexual dysfunction
Hubbard, L. C., Rajfer, J., & Rambhatla, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00115-1
Suspected hypogonadism and the importance of confirming the diagnosis - a case report
Marian, S., & McIntyre, P. (2023) · European Journal of Medical Case Reports · doi:10.24911/ejmcr/173-1678738418
Testosterontherapie: injizierbare Androgene
Yassin, A. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_15
Männlicher Hypogonadismus und Alterung: ein Update
Iglesias, P., Núñez, A., & Díez, J. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-65245-5_9
Association between hypogonadism and severity of chronic obstructive pulmonary disease: A cross-sectional study
Castro, H. M., Furcada, J. M., Vito, E. L. D., Suarez, S. M., Knoblovits, P., & Costanzo, P. (2025) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2024.08.009
Hypogonadism in Fathers and Perinatal Outcomes in Offspring: A Retrospective Analysis of U.S. Claims Data
Hernandez-Vegas, E., Moghalu, O. I., Horns, J. J., Ramsay, J. M., Dehghanbanadaki, H., Fendereski, K., Gross, K. X., Pastuszak, A. W., & Hotaling, J. (2025) · Urology · doi:10.1016/j.urology.2025.03.003
Effects of Human Chorionic Gonadotropin Therapy on Gonadal Function in Men Clinically Confirmed with Subfertility: An Interventional Study at a Teaching Hospital, Ghana
Aidoo, S., Afoko, A. A., Adams, Y., Dapare, P. P. M., Bani, S. B., Afoko, V., & Alliah, V. (2025) · Open Journal of Urology · doi:10.4236/oju.2025.153010
Cell Therapy for Testosterone Deficiency and Male Sexual Dysfunction
Hoang, V. T., & Sinh, N. T. T. (2025) · Springer eBooks · doi:10.1007/978-981-96-1261-1_21
"Pay-For-Delay": preventing competition in pharmaceutical marketsPreprint
Sandin, A. M. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5308812
Testosterone Therapy in Men with Functional Hypogonadism
Mauvais‐Jarvis, F. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_15
Male Testosterone Deficiency and Therapy in Primary Care
David, J. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_16
Practical Perspectives in Testosterone Therapy
Salter, C. A., Mulhall, J. P., & Schlegel, P. N. (2025) · Springer eBooks · doi:10.1007/978-3-031-55405-6_50
The role of sex and gender in the proinflammatory status in aging and longevity
Witkowski, J. M., Fülöp, T., & Bryl, E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27398-8.00018-6
Testosterone and Prostate Cancer
Khera, M., Saffati, G., & Rendon, D. O. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_32
Testosterone Measurement, Use and Misuse
Handelsman, D. J. (2025) · Springer eBooks · doi:10.1007/978-3-031-96376-6_17
2025 ICM: Corticosteroids or Disease-Modifying Antirheumatic Drugs
Choe, H., Borim, F. M., Lum, Z. C., Abedi, A. A., Anyaehie, U. E., Barretto, J. M., Dragosloveanu, Ş., Goodman, S. M., Guerra-Farfán, E., Han, S. B., et al. (2025) · The Journal of Arthroplasty · doi:10.1016/j.arth.2025.08.042
Treatment Options for Testosterone Replacement Therapy
Khera, M. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-179-0_10
Hypogonadism and Prostate Cancer: To Treat or Not to Treat
Khera, M. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4405-2_6
Low Testosterone Level in Men and Quality of Life
(2012) · SpringerReference · doi:10.1007/springerreference_73481
Hypogonadotropic Hypogonadism in Empty Sella Syndrome: A Case Report and Review of the Literature
Adib, E., Zakeri, A., & Banaei, S. (2025) · مجله دانشگاه علوم پزشکی اردبیل · doi:10.61882/jarums.25.3.367
Testosterone protects from metabolic syndrome-associated lung dysfunction in a high-fat diet rabbit model
Guarnieri, G., Comeglio, P., Filippi, S., Cellai, I., Acciai, G., Bartolucci, G., Pini, A., Amedei, A., Silvestri, L., Garella, R., et al. (2026) · Endocrinology · doi:10.1210/endocr/bqag048
Hongkou Advanced Research on Metabolism and Obesity iNtervention studY (HARMONY): a protocol for a longitudinal cohort study
Lin, C., Chen, W., Liu, S. X., Cao, B., Ge, Y., Li, Y., Liu, Y., Guo, T., Xu, J., & Wang, C. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-115236
Unexpected resolution of chronic gastroesophageal reflux disease with testosterone replacement therapy
Tamang, R., Disney, B., & Foster, J. (2026) · JCEM Case Reports · doi:10.1210/jcemcr/luag082
Pituitary Axis Impacts and Effectiveness of Clomiphene and Human Chorionic Gonadotropin in Treating Hypogonadism: Cohort Study
Clift, A. K., Johnson, H. H., Huang, D. R., & Ramasamy, R. (2026) · The World Journal of Men s Health · doi:10.5534/wjmh.250422
Efficacy of Medical Interventions for Erectile Dysfunction after Prostate Cancer Treatment: A Systematic Review and Network Meta-Analysis
Eshetie, S., Ejekpokpo, O., Charlick, M., Tiruye, T. Y., Jay, A., Higgs, B., Shepherd, A., & Beckmann, K. (2026) · The World Journal of Men s Health · doi:10.5534/wjmh.260050
Study on the mechanism of SW inhibiting testosterone synthesis in mouse Leydig cells
Chen, Z., Zhou, Y., He, X., Liu, J., Zhao, Y., Liu, J., Shi, S., Gou, Y., Hong, J., Ye, D., et al. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1912572
Anthropometric, functional and lifestyle-related factors associated with testosterone levels among middle-aged men in Uzbekistan: protocol for a population-based cross-sectional study
Abdurakhimov, A., & Azizova, F. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-123601
Low testosterone promotes anxiety through astrocytic mitochondrial remodelling at the nucleus accumbens blood-brain barrierPreprint
Abrantes, H. D. C., Depaauw-Holt, L. R., Ülgen, D. H., Giulio, C. D., Barbetti, M., Gebara, E., Hollis, F., Solano, J. L., Schlotterose, L., Ménard, C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.03.749088
Endogenous androgens, physical and cognitive function in healthy midlife men: A systematic review
Keren, D., Hayek, R., Toledano, Y., Strauss, T., Springer, S., & Goshen, A. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112257
Current Evidence on Late-Onset Hypogonadism in Primary Care: A Scoping Review Protocol
Tashiro, N., Otsuka, Y., Soejima, Y., Masuda, Y., Tokumasu, K., Sakurada, Y., Matsuki, N., Mitsuda, E., Shiraishi, K., Nakatsuka, M., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15207776
Update on testosterone deficiency and therapeutic options for testosterone replacement therapy
Thompson, T., Mubarak, M., Jones, T. H., Pearce, I., & Modgil, V. (2026) · Nature Reviews Urology · doi:10.1038/s41585-026-01190-3
The role of insulin in advanced prostate cancer
McKenzie, I. R. (2011)

Authors: MULLIGAN, T., FRICK, M. F., ZURAW, Q. C., STEMHAGEN, A., & MCWHIRTER, C.
Affiliations: University of Florida (US)
Covance (United States) (US)
Solvay (United States) (US)
Corresponding author: MULLIGAN, T.
ORCID: MULLIGAN, T.
Venue: International Journal of Clinical Practice
Publisher: Hindawi Limited
Published: 2008-10-09
Volume: 60
Issue: 7
Pages: 762-769
ISSN: 1368-5031 (ISSN-L)
DOI: 10.1111/j.1742-1241.2006.00992.x
PMC: PMC1569444
OpenAlex: W1667402504
Cited by: 767
References: 24
Citations by year: 2026: 14 · 2025: 37 · 2024: 37 · 2023: 32 · 2022: 35 · 2021: 42 · 2020: 44 · 2019: 38 · 2018: 34 · 2017: 54 · 2016: 60 · 2015: 40 · 2014: 58 · 2013: 60 · 2012: 42
FWCI: 18.19
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 2518 d)
Locations: International Journal of Clinical Practice (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords: hypogonadism, androgen deficiency, prevalence, primary care, free testosterone, bioavailable testosterone, comorbidities, hypertension, hyperlipidemia, diabetes mellitus, obesity, prostate diseases, asthma, chronic obstructive pulmonary disease, testosterone replacement therapy
MeSH terms: Aged, Aged, 80 and over, Humans, Hypogonadism, Male, Middle Aged, Testosterone, United States, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks